"This document outlines the regulatory framework for the Medical Device Single Audit Program (MDSAP) audit approach, providing key updates and guidance for conducting audits.
As of August 6, 2024, several modifications have been made to the MDSAP audit processes, including updates to tasks related to device marketing authorization, facility registration, purchasing, adverse event reporting, and quality management systems (QMS). References to MHLW MO169 have been harmonized with ISO 13485:2003 throughout, with updates to comply with U.S. accessibility requirements.
The MDSAP audit covers critical areas such as QMS planning, risk management, document control, and device distribution. The audit sequence is structured around key processes like management, measurement, analysis, improvement, design, and development. Sterility control for medical devices is emphasized during initial or recertification audits, while surveillance audits focus on validated process parameters and product release.
Annexes provide additional guidance on specific areas such as sterile medical devices, adverse event reporting, and Japan’s QMS ordinance revision. These updates ensure that the MDSAP audit process aligns with global regulatory standards, streamlining compliance for medical device manufacturers."
Region: United States of America
Reach out to us and let’s unravel your Regulatory puzzle together. Unlock regulatory solutions with our global subject matter experts and tap into a wealth of regulatory intelligence.
Speak to an ExpertSay goodbye to hours spent on Regulatory research, with our AI powered Regulatory Advisor. Get verified Regulatory information from Health authorities across 150+ countries.
Unlock efficiency with Freya,
your Regulatory time saver!